Hormone replacement therapy (HRT) for estrogen deficiency symptoms in postmenopausal women >1 year post menopause. Prevention of postmenopausal osteoporosis in women with an increased risk of future osteoporosis fractures that are intolerant of, or contraindicated for, other medicinal products approved for the prevention of osteoporosis.